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Abstract
Desminopathy is a genetically heterogeneous disorder with autosomal dominant pattern of
inheritance in most affected families; the age of disease onset is on average 30 years. We studied a
patient with a history of recurrent episodes of syncope from infancy who later developed second-
degree AV block and restrictive cardiomyopathy; she subsequently suffered several episodes of
ventricular tachyarrhythmia requiring implantation of bicameral defibrillator. Neurological
examination revealed rapidly progressive bilateral facial weakness, winging of the scapulae,
symmetric weakness and atrophy of the trunk muscles, shoulder girdle and distal muscles of both
upper and lower extremities. Muscle biopsy demonstrated signs of myofibrillar myopathy with
prominent subsarcolemmal desmin-reactive aggregates. Molecular analysis identified a homozygous
deletion in DES resulting in a predicted in-frame obliteration of seven amino acids (p.R173_E179del)
in the 1B domain of desmin. We describe the youngest known desminopathy patient with severe
cardiomyopathy and aggressive course leading to the devastation of cardiac, skeletal and smooth
musculature at an early age.
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Myofibrillar myopathy is a familial or sporadic disorder caused by mutations in DES, CRYAB,
MYOT, ZASP, FLNC and BAG3 genes [1]. The most frequent of these five subtypes,
desminopathy, is a disease that usually manifests between the second and fourth decades of
live with skeletal muscle weakness often followed by cardiac conduction disturbances and
cardiomyopathy [2,3]. Desminopathy is inherited with an autosomal dominant pattern or results
from de novo mutations; autosomal recessive mutations are rare [2].
Desmin is a member of the intermediate filament family of cytoskeletal proteins expressed in
striated, cardiac and smooth muscle. In mature striated muscle, desmin filaments surround the
Z discs, interconnect them to each other and link the contractile apparatus to the sarcolemma,
cytoplasmic organelles and the nuclear membrane [4]. In cardiac muscle, desmin is increased
at intercalated discs and represents the major component of the Purkinje fibers [5]. Human
desmin is encoded by a single copy gene (DES) located in chromosome 2q35 band [6]; it
encompasses nine exons within an 8.4 kb region and codes for 476 amino acids [7]. The gene
is highly conserved among vertebrate species. In accordance with its function, desmin protein
is organized into three domains: a highly conserved alpha-helical core of 308 amino acid
residues flanked by globular N- and C-terminal (“head” and “tail”) structures [4]. The alpha-
helical core maintains a seven-residue (heptad) repeat pattern that guides two polypeptides into
formation of a homopolymeric coiled-coil dimer, the elementary unit of desmin filament [8].
Multiple mutations in the desmin gene, point substitutions, insertion, small in-frame deletions
and a larger exon-skipping deletion have been identified [2]. The majority of these mutations
are located in conserved alpha-helical segments [2]. Filament and network assembly studies
indicate that most but not all disease-causing mutations make desmin assembly-incompetent
and able to disrupt a pre-existing filamentous network in dominant-negative fashion [9].
We provide a clinical, myopathological and molecular description of a patient suffering from
an infantile onset severe cardiac, skeletal and smooth muscle myopathy due to a homozygous
DES deletion.
2. Patient and methods
The patient was studied at the Neurology Division, Hospital Clínico Universitario de Zaragoza.
Routine laboratory tests, echocardiography, cardiac MRI, coronary angiography, cardiac
electrophysiological study, brain MRI, motor and sensory nerve conduction studies and
electromyography were performed before initiation of muscle biopsy and molecular analysis.
An open muscle biopsy was performed on the left deltoid muscle and biopsy tissue processed
by routine histological, histochemical techniques, and desmin immunohistochemistry as
previously described [10]. A small sample was used for ultrastructural examination using
standard methods.
Sequence analysis of desmin and alphaB-crystallin genes was performed in the patient and her
unaffected parents after informed consent was obtained from each individual. The study
protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki. Genomic DNA
was isolated from peripheral lymphocytes and used for amplification in polymerase chain
reaction (PCR) with intronic primers. The resulting PCR-produced fragments were purified by
QIAquick PCR Purification Kit (Qiagen, Valencia, CA) and directly sequenced using
BigDyeTerminator™ sequencing protocol on an automated 3100 ABI Prism® Genetic
Analyzer (Applied Biosystems, Foster City, CA). Data was extracted and analyzed using
Sequencing Analysis software (Applied Biosystems, Foster City, CA).
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The patient had repetitive episodes of syncope since the age of 6 months which were initially
attributed to right posteroseptal accessory conduction pathway and subsequently diagnosed as
Wolf-Parkinson-White (WPW) syndrome. Transthoracic echocardiography, cardiac MRI and
coronary angiography performed during infancy were assessed as normal. At the age of 3 years,
the patient developed progressive syncopal, pre-syncopal and cyanotic attacks. On examination
at the age of 15 years, she had a long-narrow face with bilateral facial weakness, ptosis,
symmetrical winging of the scapulae and poor muscle bulk. There was symmetric atrophy of
the masseter, temporalis, sternocleidomastoid and trunk muscles, bilateral pes cavus, and mild
muscle weakness involving the shoulder girdle and distal muscles of the upper and lower
extremities. Deep tendon reflexes were all hypoactive. Sensation was intact. There was no
clinical myotonia. Blood tests including serum electrolytes, lactate curve, albumin, vitamin
B12, and anti-ganglioside antibody levels yielded normal results. Creatine kinase was elevated
to twice-normal level. Sensory nerve conduction studies were normal, whereas motor nerve
studies showed low amplitude of the motor potentials with normal latencies and conduction
velocities. Needle electromyography demonstrated abundant complex repetitive discharges,
some myotonic discharges and occasional fibrillation potentials. During voluntary contraction,
a myopathic recruitment pattern was recorded. Cerebral MRI was normal. Respiratory function
tests did not show any abnormalities.
Cardiac electrophysiological study failed to show accessory conduction pathway or induced
ventricular or supraventricular dysrhythmia. Twenty-four-hour Holter monitoring revealed
monomorphic and polymorphic ventricular tachycardia, occasional prolongation of the QT
interval and second degree AV block (Figure 1). In view of these life-threatening arrhythmias
and risk of progression to higher-degree AV block, an automatic implantable cardioverter
defibrillator (AICD) and pacemaker device were implanted (Figure 2).
Three years later, at age 18 years, the patient suffered several consecutive episodes of
ventricular tachyarrhythmia requiring implantation of bicameral defibrillator.
Echocardiography showed normal morphology of the left ventricle, mild left systolic
dysfunction (left ventricular ejection fraction, LVEF 45%) and slight right ventricular
dilatation with mild systolic dysfunction. The atria were markedly enlarged. Doppler analysis
of mitral flow revealed abnormal filling indicative of restrictive cardiomyopathy.
Skeletal muscle weakness rapidly progressed. Developing diarrhea, vomiting and weight loss
suggested involvement of smooth intestinal muscles. No cardiac or intestinal biopsy was
performed at this time due to patient’s further decline. She died from cardiac failure before her
21st birthday. Post-mortem examination was not performed.
The patient’s parents are in a consanguineous marriage (uncle and niece), in which the patient
was the only child. The patient’s mother is in good health, the father has been diagnosed with
acquired immuno-mediated peripheral neuropathy, currently in remission. No other first or
second degree family member was affected with cardio- or skeletal myopathy like disease.
3.2. Myopathology
Muscle biopsy showed an excessive variation in fiber size, ranging from 15 to 40 microns.
More than 90% of fibers had well-defined peripheral and often multiple deposits of
homogeneous eosinophilic material (Figure 3A) that stained different shades of green with
Engel trichrome, appeared Congo red positive and was strongly immunoreactive with
antibodies to desmin (Figure 3B). These inclusions showed slight PAS positivity, were non-
reactive against alpha-glycerophosphate dehydrogenase with and without substrate, and devoid
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of oxidative enzyme and ATPase activities. Several muscle fibers contained small vacuoles
rimmed with granular basophilic material. Ultrastructural examination revealed a matrix of
granulofilamentous material with amorphous, granular and electron-dense deposits forming a
thick reticular network with interspersed, disorganized thin filaments (Figure 3C).
3.3 Mutation Detection Studies
Analysis of the patient’s genomic DNA for mutations in desmin and alphaB-crystallin genes
identified a homozygous deletion of 21 nucleotides predicting an in-frame loss of 7 amino
acids (RARVDVE) from Arg173 through Glu179 (p.R173_E179del) in the 1B helix domain
of the desmin molecule. The mutation abolishes part of protein structure representing a full
heptad. The entire desmin rod normally contains 35 full heptads, and the 1B helix domain
consists of 14. The patient’s mother and father was each heterozygous for this mutation.
4. Discussion
We report the youngest known molecularly identified patient suffering of severe desminopathy
characterized by infantile onset of cardiac arrhythmia followed by skeletal weakness and
cardiac failure due to a homozygous desmin p.Arg173_Glu179del mutation. The mutation
identified in our patient is located at the beginning of the 1B domain of the desmin alpha-helical
core, the site known to be critically involved in filament assembly [8] and interactions with
other cellular proteins [11].
The only closely related observation reported in the literature was the case of Muñoz-Mármol
et al. [12], in which an identical homozygous deletion of 21 nucleotides in the DES gene caused
a severe clinical syndrome. Their patient was a 15-year-old boy who developed generalized
muscular weakness and atrophy, predominantly in distal muscles of the upper extremities, AV
block requiring implantation of a permanent pacemaker, respiratory failure, and intestinal
malabsorption [12,13]. The patient died at the age of 28 years. Echocardiography showed
dilatation of the right cardiac chambers. Abundant subsarcolemmal crescent-shaped strongly
eosinophilic masses in the skeletal myofibers and centrally located eosinophilic bodies in the
cardiomyocytes were immunoreactive for desmin and ubiquitin [13]. Myopathological
characteristics of the inclusions observed in our case match this description, but at the same
time they were different from the amorphous patches previously identified in the majority of
patients with dominant or de novo desmin mutations [2].
Atrioventricular conduction abnormalities requiring urgent implantation of a permanent
pacemaker is a frequent feature of desminopathy. In a quarter of desminopathy patients the
illness presents with cardiomyopathy, and heart disease is seen in more than 60% of patients
in the advanced stages of illness [2]. Restrictive, dilated and hypertrophic cardiomyopathy have
been documented [1-3,10]. The age of disease onset in cases associated with cardiomyopathy
tends to be earlier than in patients with isolated skeletal myopathy, and the illness more severe.
Sudden death occurring in a significant number of desminopathy patients is the consequence
of ventricular arrhythmia; this condition has previously been diagnosed and associated with
desminopathy in a living patient [14]. The current observation additionally confirms that
patients with desmin-related cardiomyopathy are at high risk of developing ventricular
arrhythmia and therefore should be considered candidates for AICD implantation even before
ventricular dysfunction becomes evident. The identification of the genetic cause of pediatric
cardiomyopathy has therefore tremendous significance in patient management and genetic
counseling. Ventricular arrhythmias have also been documented as an associated sign in several
inherited myopathies including myotonic dystrophy [15] and laminopathy [16].
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In about 6% of patients with desminopathy, the inheritance pattern was autosomal recessive;
patients with recessive mutations develop the disease in their childhood (average 5 years) [2].
Our observation is the first known case of infantile-onset desmin mutation-associated
cardiomyopathy and the first case exhaustively proven to be inherited as an autosomal recessive
trait. The homozygous p.Arg173_Glu179del mutation prevented assembly of desmin filaments
and compromised the ability of desmin to form an intermediate filament network in transiently
transfected MCF-7 cells [12], providing a confirmation of high pathogenic potential. At the
same time, the mutation that is clearly changing protein structure in a highly conserved region
did not cause pathogenic effects in the patient’s parents who are heterozygous for the
p.Arg173_Glu179del alteration.
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Basal electrocardiogram. Rhythm strip obtained with an insertable loop recorder (IRL)
demonstrate high degree 4:1 atrioventricular block
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Electrogram rhythm strip obtained with the automatic implantable cardioverter-defibrillator
(AICD). Top strip: ventricular flutter, bottom strip: ventricular fibrillation. Both were
recognized and successfully treated by the AICD.
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Patient’s muscle biopsy. Prominent crescent-shaped eosinophilic masses located under the
sarcolemma, sometimes associated with basophilic granular material (A), and displaying
strong desmin immunoreactivity (B). Under electron microscopy, a matrix of dense
granulofilamentous material is observed among the myofibrils (C). Cryostat sections, original
magnification in A and B x200; C x5000. Modified from reference 2, with permission from
Landes Bioscience and Springer Science+Business Media.
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